• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit.

作者信息

Vanhomwegen Charlotte, Veliziotis Ioannis, Malinverni Stefano, Konopnicki Deborah, Dechamps Philippe, Claus Marc, Roman Alain, Cotton Fréderic, Dauby Nicolas

机构信息

Department of Internal Medicine, Erasme Hospital, Université Libre de Bruxelles (ULB), route de Lennick 808, Brussels, 1070, Belgium.

Intensive Care Unit, CHU Saint Pierre, Université Libre de Bruxelles (ULB), Rue haute 322, Brussels, 1000, Belgium.

出版信息

Ir J Med Sci. 2021 Nov;190(4):1649-1652. doi: 10.1007/s11845-020-02485-z. Epub 2021 Jan 16.

DOI:10.1007/s11845-020-02485-z
PMID:33453014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7811155/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9854/7811155/8a60c30bdd28/11845_2020_2485_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9854/7811155/8a60c30bdd28/11845_2020_2485_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9854/7811155/8a60c30bdd28/11845_2020_2485_Fig1_HTML.jpg

相似文献

1
Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit.降钙素原能准确预测入住重症监护病房的新冠肺炎患者的死亡率，但不能预测细菌感染情况。
Ir J Med Sci. 2021 Nov;190(4):1649-1652. doi: 10.1007/s11845-020-02485-z. Epub 2021 Jan 16.
2
[Not Available].[无可用内容]。
Salud Publica Mex. 2021 Sep 4;63(5):583-584. doi: 10.21149/12951.
3
Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection.严重 COVID-19 患者降钙素原浓度升高可能不反映细菌合并感染。
Ann Clin Biochem. 2021 Sep;58(5):520-527. doi: 10.1177/00045632211022380. Epub 2021 Jun 18.
4
The dynamics of procalcitonin in COVID-19 patients admitted to Intensive care unit - a multi-centre cohort study in the South West of England, UK.入住重症监护病房的COVID-19患者中降钙素原的动态变化——英国英格兰西南部的一项多中心队列研究
J Infect. 2021 Jun;82(6):e24-e26. doi: 10.1016/j.jinf.2021.03.011. Epub 2021 Mar 18.
5
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.探讨降钙素原测定在 COVID-19 中的作用：一项针对住院患者的选定队列研究。
Clin Chem Lab Med. 2020 Nov 19;59(2):433-440. doi: 10.1515/cclm-2020-1361.
6
Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or "just" a marker of bacterial coinfection?降钙素原是人类对 SARS-CoV-2 感染的免疫反应的一部分，还是仅仅是细菌合并感染的标志物？
Curr Res Transl Med. 2021 May;69(2):103289. doi: 10.1016/j.retram.2021.103289. Epub 2021 Mar 24.
7
Promise and Limitations of Procalcitonin to Identify Bacterial Infections in the Pediatric Intensive Care Unit.降钙素原在儿科重症监护病房识别细菌感染中的前景与局限性
J Pediatr. 2016 Dec;179:7-9. doi: 10.1016/j.jpeds.2016.09.031. Epub 2016 Oct 4.
8
A retrospective analysis of intensive care unit patients during the pandemic period.大流行期间重症监护病房患者的回顾性分析。
Bratisl Lek Listy. 2021;122(11):805-810. doi: 10.4149/BLL_2021_128.
9
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.降钙素原指导在危重症患者中缩短抗生素治疗时间的疗效和安全性：一项随机、对照、开放标签试验。
Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.
10
Procalcitonin-guided antibiotic therapy duration in critically ill adults.降钙素原指导下的危重症成年患者抗生素治疗疗程
AACN Adv Crit Care. 2015 Apr-Jun;26(2):99-106. doi: 10.1097/NCI.0000000000000079.

引用本文的文献

1
The subsets of blood circulating T-cells associated with the development and prognosis of coinfection in patients with critical COVID-19.与危重型新型冠状病毒肺炎患者合并感染的发生及预后相关的循环T细胞亚群
Front Immunol. 2025 May 9;16:1586302. doi: 10.3389/fimmu.2025.1586302. eCollection 2025.
2
Role of Procalcitonin as a Prognostic Biomarker in Hospitalized COVID-19 Patients: A Comparative Analysis.降钙素原作为住院COVID-19患者预后生物标志物的作用：一项比较分析。
Biomark Insights. 2025 May 15;20:11772719241296624. doi: 10.1177/11772719241296624. eCollection 2025.
3
Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review.
C反应蛋白和降钙素原对COVID-19患者进行抗菌药物管理而言安全且有用吗？一项范围综述。
Antimicrob Steward Healthc Epidemiol. 2024 Sep 12;4(1):e129. doi: 10.1017/ash.2024.372. eCollection 2024.
4
Role of biomarkers in antimicrobial stewardship: physicians' perspectives.生物标志物在抗菌药物管理中的作用：医生的观点。
Korean J Intern Med. 2024 May;39(3):413-429. doi: 10.3904/kjim.2023.558. Epub 2024 Apr 30.
5
Lung Ultrasound Score as a Predictor of Failure to Wean COVID-19 Elderly Patients off Mechanical Ventilation: A Prospective Observational Study.肺部超声评分对预测 COVID-19 老年患者脱机率机械通气失败的作用：一项前瞻性观察研究。
Clin Interv Aging. 2024 Feb 19;19:313-322. doi: 10.2147/CIA.S438714. eCollection 2024.
6
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients-Results from a Retrospective Observational Study in Intensive Care Units.降钙素原（PCT）作为细菌二重感染生物标志物的可靠性降低：对危重症COVID-19患者中PCT驱动的抗生素管理的担忧——来自重症监护病房的一项回顾性观察研究结果
J Clin Med. 2023 Sep 24;12(19):6171. doi: 10.3390/jcm12196171.
7
[Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy].[危重症 COVID-19 患者的细菌合并感染：发生率、影响及抗菌治疗需求]
Rev Esp Quimioter. 2023 Dec;36(6):612-620. doi: 10.37201/req/060.2023. Epub 2023 Sep 25.
8
Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis.降钙素原对 COVID-19 合并感染的预测价值：系统评价和荟萃分析。
Virol J. 2023 May 8;20(1):92. doi: 10.1186/s12985-023-02042-x.
9
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者的抗菌药物耐药性：系统评价和荟萃分析。
Lancet Microbe. 2023 Mar;4(3):e179-e191. doi: 10.1016/S2666-5247(22)00355-X. Epub 2023 Jan 31.
10
The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults.生物标志物在成人流感和新冠病毒感染社区获得性肺炎中的作用
Antibiotics (Basel). 2023 Jan 12;12(1):161. doi: 10.3390/antibiotics12010161.